Assessment of the Safety, Growth, and Gut Microbiota Modulation of Neonates Consuming Infant Formula with Bifidobacterium animalis ssp. lactis CP-9 or Lactobacillus salivarius AP-32: Insights from a Four-Month Clinical Study in Newborn Infants Under Two Months Old

doi:10.21203/rs.3.rs-3718044/v1

Assessment of the Safety, Growth, and Gut Microbiota Modulation of Neonates Consuming Infant Formula with Bifidobacterium animalis ssp. lactis CP-9 or Lactobacillus salivarius AP-32: Insights from a Four-Month Clinical Study in Newborn Infants Under Two Months Old

2023 · doi:10.21203/rs.3.rs-3718044/v1

preprint OA: closed

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher →

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-05-20T01:45:00.602351+00:00